{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:55:01Z","timestamp":1795107301442,"version":"4.10.3"},"reference-count":24,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inactivating mutations of the Ten-Eleven Translocation 2 (TET2) gene were first identified in myeloid malignancies and more recently in peripheral T-cell lymphomas (PTCLs). In the present study, we investigated the presence of TET2 coding sequence mutations and their clinical relevance in a large cohort of 190 PTCL patients. TET2 mutations were identified in 40 of 86 (47%) cases of angioimmunoblastic T-cell lymphoma (AITL) and in 22 of 58 (38%) cases of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), but were absent in all other PTCL entities, with the exception of 2 of 10 cases of enteropathy-associated T-cell lymphoma. Among PTCL-NOS, a heterogeneous group of lymphoma-comprising cases likely to derive from Th follicular (TFH) cells similarly to AITL, TET2 mutations were more frequent when PTCL-NOS expressed TFH markers and\/or had features reminiscent of AITL (58% vs 24%, P = .01). In the AITL and PTCL-NOS subgroups, TET2 mutations were associated with advanced-stage disease, thrombocytopenia, high International Prognostic Index scores, and a shorter progression-free survival.<\/jats:p>","DOI":"10.1182\/blood-2012-02-408542","type":"journal-article","created":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T21:57:19Z","timestamp":1341439039000},"page":"1466-1469","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":456,"title":["Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters"],"prefix":"10.1182","volume":"120","author":[{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"first","affiliation":[{"name":"Inserm U955, Cr\u00e9teil, France;"},{"name":"Universit\u00e9 Paris Est, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Couronn\u00e9","sequence":"additional","affiliation":[{"name":"Inserm U985, Institut Gustave Roussy; Universit\u00e9 Paris, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, H\u00f4pital Pessac, Bordeaux, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Ja\u00efs","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Statistiques. H\u00f4pital Necker, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Travert","sequence":"additional","affiliation":[{"name":"Inserm U955, Cr\u00e9teil, France;"},{"name":"Universit\u00e9 Paris Est, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, H\u00f4pital Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournillac","sequence":"additional","affiliation":[{"name":"Service de Th\u00e9rapie Cellulaire et d'H\u00e9matologie Clinique Adulte, Universit\u00e9 d'Auvergne, Inserm CIC-501, Centre Hospitalier Universitaire Clermont-Ferrand H\u00f4pital Estaing, Clermont-Ferrand, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Rousset","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Anatomie Pathologique, Centre Hospitalier Universitaire Gui de Chauliac, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Anatomie Pathologique, H\u00f4pital Saint-Antoine, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob A.","family":"Cairns","sequence":"additional","affiliation":[{"name":"Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, University Health Network, Toronto, ON;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak","family":"Mak","sequence":"additional","affiliation":[{"name":"Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, University Health Network, Toronto, ON;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bastard","sequence":"additional","affiliation":[{"name":"Inserm U918, Universit\u00e9 de Rouen, Centre Henri Becquerel, Rouen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[{"name":"Inserm U985, Institut Gustave Roussy; Universit\u00e9 Paris, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"Inserm U955, Cr\u00e9teil, France;"},{"name":"Universit\u00e9 Paris Est, Cr\u00e9teil, France;"},{"name":"D\u00e9partement de Pathologie, Groupe Henri-Mondor Albert-Chenevier, AP-HP, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2019111808191842700_B1","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers.","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111808191842700_B2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"issue":"5929","key":"2019111808191842700_B3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"issue":"6047","key":"2019111808191842700_B4","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"issue":"3","key":"2019111808191842700_B5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.stem.2011.08.007","article-title":"TET family proteins and their role in stem cell differentiation and transformation.","volume":"9","author":"Cimmino","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2019111808191842700_B6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111808191842700_B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"17","key":"2019111808191842700_B8","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111808191842700_B9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma.","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"issue":"25","key":"2019111808191842700_B10","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"2019111808191842700_B11","article-title":"International Agency for Research on Cancer.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008"},{"issue":"4","key":"2019111808191842700_B12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2019111808191842700_B13","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"22","key":"2019111808191842700_B14","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"2019111808191842700_B15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/asheducation.V2008.1.272.0010272","article-title":"Pathobiology and molecular profiling of peripheral T-cell lymphomas.","volume":"2008","author":"de Leval","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"2019111808191842700_B16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers.","volume":"32","author":"Rodr\u00edguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2019111808191842700_B17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111808191842700_B18","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111808191842700_B19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111808191842700_B20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"7337","key":"2019111808191842700_B21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma.","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"issue":"2","key":"2019111808191842700_B22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"7360","key":"2019111808191842700_B23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"9","key":"2019111808191842700_B24","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/7\/1466\/1498655\/zh803312001466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/7\/1466\/1498655\/zh803312001466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:38:44Z","timestamp":1574084324000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/7\/1466\/30738\/Recurrent-TET2-mutations-in-peripheral-Tcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,8,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-02-408542","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]}}}